Brief: First Wave Biopharma To Direct Resources For Filing IND & Mid-Stage Study Of Adrulipase Formulation

GridAI Technologies

19/09/2022 12:16

Sept 19 (Reuters) - First Wave BioPharma Inc  FWBI.O :
    * FIRST WAVE BIOPHARMA - MADE DECISION TO DIRECT NEAR-TERM
RESOURCES TOWARDS FILING OF IND & PHASE 2 CLINICAL TRIAL OF NEW
ADRULIPASE FORMULATION
    * FIRST WAVE BIOPHARMA INC - WILL BE DEVOTING FEWER
RESOURCES TO
OUR NICLOSAMIDE PROGRAMS
    * FIRST WAVE BIOPHARMA - TAKEN STEPS TO IMPROVE BALANCE
SHEET,
INCLUDING SETTLING LAWSUIT FILED AGAINST US BY FORMER
STOCKHOLDERS OF FIRST WAVE BIO

Source text for Eikon:  ID:nGNX8xzkhG 
Further company coverage:  FWBI.O 

 ((Reuters.Briefs@thomsonreuters.com;))